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Background
Abnormal distribution, modification and aggregation of
transactivation response DNA-binding protein 43 (TDP-
43) are the hallmarks of multiple neurodegenerative dis-
eases, especially frontotemporal lobar degeneration with
ubiquitin-positive inclusions (FTLD-U) and amyotrophic
lateral sclerosis (ALS).
Results
To explore the pathogenic properties of mutant forms of
TDP-43, we generated and characterized two mouse lines
expressing human TDP-43 carrying the M337V mutation
(hTDP-43M337V). We found hTDP-43M337V was expressed
primarily in the nuclei of neurons in the brain and spinal
cord, intranuclear and cytoplasmic phosphorylated TDP-
43 aggregates were frequently detected, and the levels of
TDP-43 LMW products of ~25 kDa and ~35 kDa species
were also increased. Overexpression of hTDP-43M337V
dramatically down regulated the levels of mouse TDP-43
(mTDP-43) protein and RNA, indicating TDP-43 levels
are tightly controlled in mammalian systems. TDP-
43M337V mice displayed reactive gliosis, widespread ubiqui-
tination, chromatolysis, gait abnormalities, and early
lethality. Abnormal cytoplasmic mitochondrial aggregates
and abnormal phosphorylated tau were also detected in
the mice.
Conclusion
While overexpression of hTDP-43 in wild-type TDP-43
and TDP-43M337V mouse models produces similar pheno-
types, our results suggest that overexpression of the
hTDP-43M337V can cause neuronal dysfunction due to its
effect on a number of cell organelles and proteins, such as
mitochondria and TDP-43, that are critical for neuronal
activity.
Published: 7 February 2012
doi:10.1186/1750-1326-7-S1-L19
Cite this article as: Petrucelli: Mechanisms and models of TDP-43
proteinopathies. Molecular Neurodegeneration 2012 7(Suppl 1):L19.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Mayo Clinic Jacksonville, USA
Petrucelli Molecular Neurodegeneration 2012, 7(Suppl 1):L19
http://www.molecularneurodegeneration.com/content/7/S1/L19
© 2012 Petrucelli; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.